Literature DB >> 33801447

Dose-Dependent Solubility-Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions.

Kazuya Sugita1,2, Noriyuki Takata2, Etsuo Yonemochi1.   

Abstract

We investigated the solubility-permeability interplay using a solubilizer additive under non-sink conditions. Sodium lauryl sulfate (SLS) was used as a solubilizer additive. The solubility and permeability of two poorly soluble drugs at various doses, with or without SLS, were evaluated by flux measurements. The total permeated amount of griseofulvin, which has high permeability, increased by the addition of SLS. On the other hand, triamcinolone, which has low permeability, showed an almost constant rate of permeation regardless of the SLS addition. The total permeated amount of griseofulvin increased by about 20-30% when the dose amount exceeded its solubility, whereas its concentration in the donor chamber remained almost constant. However, the total permeated amount of triamcinolone was almost constant regardless of dose amount. These results suggest that the permeability of the unstirred water layer (UWL) may be affected by SLS and solid drugs for high-permeable drugs. The effect of solid drugs could be explained by a reduction in the apparent UWL thickness. For the appropriate evaluation of absorption, it would be essential to consider these effects.

Entities:  

Keywords:  non-sink condition; poorly soluble drugs; solubility–permeability interplay; solubilizer additive; unstirred water layer

Year:  2021        PMID: 33801447      PMCID: PMC7998705          DOI: 10.3390/pharmaceutics13030323

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  48 in total

1.  International Conference on Harmonisation; guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. Notice.

Authors: 
Journal:  Fed Regist       Date:  2000-12-29

2.  Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect.

Authors:  Kiyohiko Sugano
Journal:  Int J Pharm       Date:  2009-12-16       Impact factor: 5.875

3.  The asymmetry of the unstirred water layer in permeability experiments.

Authors:  Timo Korjamo; Aki T Heikkinen; Pekka Waltari; Jukka Mönkkönen
Journal:  Pharm Res       Date:  2008-04-16       Impact factor: 4.200

Review 4.  Strategies to address low drug solubility in discovery and development.

Authors:  Hywel D Williams; Natalie L Trevaskis; Susan A Charman; Ravi M Shanker; William N Charman; Colin W Pouton; Christopher J H Porter
Journal:  Pharmacol Rev       Date:  2013-01       Impact factor: 25.468

Review 5.  The solubility-permeability interplay and oral drug formulation design: Two heads are better than one.

Authors:  Arik Dahan; Avital Beig; David Lindley; Jonathan M Miller
Journal:  Adv Drug Deliv Rev       Date:  2016-04-26       Impact factor: 15.470

6.  Regulatory Considerations of Bioequivalence Studies for Oral Solid Dosage Forms in Japan.

Authors:  Ryosuke Kuribayashi; Tomoko Takishita; Kenichi Mikami
Journal:  J Pharm Sci       Date:  2016-06-30       Impact factor: 3.534

7.  Theoretical and experimental studies of transport of micelle-solubilized solutes.

Authors:  G E Amidon; W I Higuchi; N F Ho
Journal:  J Pharm Sci       Date:  1982-01       Impact factor: 3.534

8.  Ranking Itraconazole Formulations Based on the Flux through Artificial Lipophilic Membrane.

Authors:  Konstantin Tsinman; Oksana Tsinman; Ram Lingamaneni; Saijie Zhu; Bernd Riebesehl; Arnaud Grandeury; Michael Juhnke; Bernard Van Eerdenbrugh
Journal:  Pharm Res       Date:  2018-06-20       Impact factor: 4.200

9.  The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.

Authors:  Yasuhiro Tsume; Deanna M Mudie; Peter Langguth; Greg E Amidon; Gordon L Amidon
Journal:  Eur J Pharm Sci       Date:  2014-01-28       Impact factor: 4.384

Review 10.  Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches.

Authors:  David Dahlgren; Hans Lennernäs
Journal:  Pharmaceutics       Date:  2019-08-13       Impact factor: 6.321

View more
  1 in total

1.  Non-Effective Improvement of Absorption for Some Nanoparticle Formulations Explained by Permeability under Non-Sink Conditions.

Authors:  Kazuya Sugita; Noriyuki Takata; Etsuo Yonemochi
Journal:  Pharmaceutics       Date:  2022-04-07       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.